Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

All results

2 results for phase ii 16 week double blind placebo controlled parallel group randomized

  • GCAptAIN

    This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…

    Ages
    50 Years - N/A
    Sexes
    All
  • IMPALA-2

    160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment with inhaled molgramostim or placebo for…

    Ages
    18 Years - N/A
    Sexes
    All